| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 6 2610-2617, Copyright © 1996 by American Association of Immunologists
ARTICLES |
M Gallicchio, P Hufnagl, J Wojta and P Tipping
Monash Centre for Inflammatory Diseases, Department of Medicine, Monash University, Melbourne, Australia.
The plasmin/plasminogen system of enzymes may be involved in leukocyte migration through the endothelial cell layer of the vascular wall during inflammatory processes associated with vascular injury, atherosclerosis, and sepsis. Synthesis of plasminogen activator inhibitor type 1 (PAI-1) by the endothelium may protect these cells and the subendothelial cell matrix from excessive degradation and retard leukocyte migration. We report in this work for the first time the down- regulation of both basal and thrombin- or endotoxin-induced PAI-1 in cultured human endothelial cells by the activated T cell product, IFN- gamma. Down-regulation of basal and thrombin- or endotoxin-induced endothelial PAI-1 protein by IFN-gamma was found to be both time and dose dependent. Decreases of up to 71% relative to thrombin- or endotoxin-treated controls, using an optimal IFN-gamma concentration of between 20 and 200 U/ml, were found for human macrovascular and microvascular endothelial cells. However, IFN-gamma did not appear to affect IL-1 alpha- and TNF-alpha-induced levels of PAI-1 protein or mRNA in these cells. Northern blot analysis paralleled protein results, showing decreases in specific endothelial cell thrombin- or LPS-induced PAI-1 mRNA expression, respectively, after incubation with IFN-gamma for 24 h. These results suggest a means by which the migration of circulating leukocytes through endothelial cell layers during inflammation may be facilitated.
This article has been cited by other articles:
|
|
 |
|
  U. R. Jag, J. Zavadil, and F. M. Stanley Insulin Acts through FOXO3a to Activate Transcription of Plasminogen Activator Inhibitor Type 1 Mol. Endocrinol., October 1, 2009; 23(10): 1587 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Mullarky, F. M. Szaba, K. N. Berggren, L. W. Kummer, L. B. Wilhelm, M. A. Parent, L. L. Johnson, and S. T. Smiley Tumor Necrosis Factor Alpha and Gamma Interferon, but Not Hemorrhage or Pathogen Burden, Dictate Levels of Protective Fibrin Deposition during Infection Infect. Immun., February 1, 2006; 74(2): 1181 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Vulin and F. M. Stanley Oxidative Stress Activates the Plasminogen Activator Inhibitor Type 1 (PAI-1) Promoter through an AP-1 Response Element and Cooperates with Insulin for Additive Effects on PAI-1 Transcription J. Biol. Chem., June 11, 2004; 279(24): 25172 - 25178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Cho, C. H. Ryu, and C. K. Oh Plasminogen Activator Inhibitor-1 in the Pathogenesis of Asthma Experimental Biology and Medicine, February 1, 2004; 229(2): 138 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Eddy Plasminogen activator inhibitor-1 and the kidney Am J Physiol Renal Physiol, August 1, 2002; 283(2): F209 - F220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Vulin and F. M. Stanley A Forkhead/Winged Helix-related Transcription Factor Mediates Insulin-increased Plasminogen Activator Inhibitor-1 Gene Transcription J. Biol. Chem., May 31, 2002; 277(23): 20169 - 20176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. K. Hansson Immune Mechanisms in Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1876 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bentzien, I. Struman, J.-F. Martini, J. Martial, and R. Weiner Expression of the Antiangiogenic Factor 16K hPRL in Human HCT116 Colon Cancer Cells Inhibits Tumor Growth in Rag1-/- Mice Cancer Res., October 1, 2001; 61(19): 7356 - 7362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.K. Hansson The stabilized plaque: will the dream come true? Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C69 - C75. [PDF]
|
|
|
|
 |
|
 H. Kawano, H. Tsuji, H. Nishimura, S. Kimura, S. Yano, N. Ukimura, Y. Kunieda, M. Yoshizumi, T. Sugano, K. Nakagawa, et al. Serotonin induces the expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells Blood, March 15, 2001; 97(6): 1697 - 1702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Martini, C. Piot, L. M. Humeau, I. Struman, J. A. Martial, and R. I. Weiner The Antiangiogenic Factor 16K PRL Induces Programmed Cell Death in Endothelial Cells by Caspase Activation Mol. Endocrinol., October 1, 2000; 14(10): 1536 - 1549. [Abstract] [Full Text]
|
|
|
|
|
|
M. Cesari and G. P. Rossi Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy Arterioscler Thromb Vasc Biol, June 1, 1999; 19(6): 1378 - 1386. [Full Text] [PDF]
|
|
|
|
|
|
N. Marx, T. Bourcier, G. K. Sukhova, P. Libby, and J. Plutzky PPAR{gamma} Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression : PPAR{gamma} as a Potential Mediator in Vascular Disease Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 546 - 551. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
